People living in regions with high levels of outdoor artificial light at night may face a higher risk of developing thyroid cancer. The finding comes from a study published early online in
CANCER
, a peer-reviewed journal of the American Cancer Society.
Over the past century, nightscapes–especially in cities–have drastically changed due to the rapid growth of electric lighting. Also, epidemiological studies have reported an association between higher satellite-measured levels of nighttime light and elevated breast cancer risk. Because some breast cancers may share a common hormone-dependent basis with thyroid cancer, a team led by Qian Xiao, PhD, of The University of Texas Health Science Center at Houston School of Public Health, looked for an association between light at night and later development of thyroid cancer among participants in the NIH-AARP Diet and Health Study, which recruited American adults aged 50 to 71 years in 1995-1996. The investigators analyzed satellite imagery data to estimate levels of light at night at participants’ residential addresses, and they examined state cancer registry databases to identify thyroid cancer diagnoses through 2011.
Among 464,371 participants who were followed for an average of 12.8 years, 856 cases of thyroid cancer were diagnosed (384 in men and 472 in women). When compared with the lowest quintile of light at night, the highest quintile was associated with a 55 percent higher risk of developing thyroid cancer. The association was primarily driven by the most common form of thyroid cancer, called papillary thyroid cancer, and it was stronger in women than in men. In women, the association was stronger for localized cancer with no sign of spread to other parts of the body, while in men the association was stronger for more advanced stages of cancer. The association appeared to be similar for different tumor sizes and across participants with different sociodemographic characteristics and body mass index.
The researchers noted that additional epidemiologic studies are needed to confirm their findings. If confirmed, it will be important to understand the mechanisms underlying the relationship between light at night and thyroid cancer. The scientists noted that light at night suppresses melatonin, a modulator of estrogen activity that may have important anti-tumor effects. Also, light at night may lead to disruption of the body’s internal clock (or circadian rhythms), which is a risk factor for various types of cancer.
“As an observational study, our study is not designed to establish causality. Therefore, we don’t know if higher levels of outdoor light at night lead to an elevated risk for thyroid cancer; however, given the well-established evidence supporting a role of light exposure at night and circadian disruption, we hope our study will motivate researchers to further examine the relationship between light at night and cancer, and other diseases,” said Dr. Xiao. “Recently, there have been efforts in some cities to reduce light pollution, and we believe future studies should evaluate if and to what degree such efforts impact human health.”
###
Additional Information
NOTE: The information contained in this release is protected by copyright. Please include journal attribution in all coverage. A free abstract of this article will be available via the
Cancer News Room
upon online publication. For more information or to obtain a PDF of any study, please contact:
Dawn Peters +1 781-388-8408 (US)
newsroom@wiley.com
Follow us on Twitter @WileyNews
Full Citation:
“Associations between artificial light at night and risk for thyroid cancer: a large U.S. cohort study.” Dong Zhang, Rena R. Jones, Peter James, Cari M. Kitahara, and Qian Xiao.
CANCER
; Published Online: February 8, 2021 (DOI: 10.1002/cncr.33392).
URL Upon Publication:
http://doi.
wiley.
com/
10.
1002/
cncr.
33392
Author Contact:
Wendi Hawthorne, Media Relations Specialist at The University of Texas Health Science Center at Houston, at
wendi.hawthorne@uth.tmc.edu
or +1 713-500-3030.
About the Journal
CANCER
is a peer-reviewed publication of the American Cancer Society integrating scientific information from worldwide sources for all oncologic specialties. The objective of
CANCER
is to provide an interdisciplinary forum for the exchange of information among oncologic disciplines concerned with the etiology, course, and treatment of human cancer. CANCER is published on behalf of the American Cancer Society by Wiley and can be accessed online.
Follow us on Twitter @JournalCancer
About Wiley
Wiley drives the world forward with research and education. Through publishing, platforms and services, we help students, researchers, universities, and corporations to achieve their goals in an ever-changing world. For more than 200 years, we have delivered consistent performance to all of our stakeholders. The Company’s website can be accessed at
http://www.
wiley.
com
.
This part of information is sourced from https://www.eurekalert.org/pub_releases/2021-02/w-sle020321.php
